MICHELLE BARNETT: Open Payments
NPI 1790827566 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,767 in 192 payments from 25 companies in 2025. Trend: 2023 $19,518 · 2024 $26,043 · 2025 $44,767
Speaker / faculty: $30,588Food & beverage: $5,291Travel & lodging: $5,283Consulting: $3,573Education: $32
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 47 | $26,927 |
| Gilead Sciences, Inc. | 46 | $11,003 |
| Mirum Pharmaceuticals, Inc. | 4 | $1,661 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $1,451 |
| Novo Nordisk Inc | 6 | $1,367 |
| ABBVIE INC. | 17 | $364 |
| Janssen Biotech, Inc. | 13 | $325 |
| GENZYME CORPORATION | 4 | $238 |
| Lilly USA, LLC | 7 | $209 |
| Ipsen Biopharmaceuticals, Inc | 8 | $182 |
Products named: REZDIFFRA, Epclusa, Livmarli, TRULANCE, TREMFYA, DUPIXENT, OMVOH, XIFAXAN.
Industry payments across CO — which companies pay providers there.
